The Breast Cancer Program is a highly successful multidisciplinary breast cancer research and treatment program composed of 44 members from 15 Departments. This program has unique strengths which have developed into successful collaborations and common goals among basic scientists, translational researchers and clinicians to promote clinical and translational research. This program has capitalized on: (1) Our expertise in locally advanced breast cancer (LABC) as a platform to study tumor metastasis and immunity, and the effects of ionizing radiation on normal and tumor tissue;(2) Our unique relationship with Bellevue Hospital Center, part of the largest public hospital group in the United States;and (3) Our experience in working with large multi-ethnic, international populations comprised of largely medically underserved and minority women with breast cancer. Since 2002, this program has developed five well funded research themes focused on invasion, metastasis and anti-angiogenic therapy, hormonal signaling in breast cancer, radiation biology and antitumor immunity, hormonal signaling, and socio-cultural research to increase participation of minority and medically underserved women in clinical trials. The members of this program have published over 90 research papers collaboratively, opened many investigator initiated clinical trials, accrued over 400 patients to trial, increased recruitment of minority women to clinical trial, developed a funded multi-ethnic/multicultural outreach-inreach program to increase accrual of minority women into screening and clinical trials, and secured $10,284,695 million dollars in peer-reviewed funding. There are four important clinical programs that are the basis for much of the collaborative translational- . clinical research platforms of the breast cancer program: (1) Role of hormonal signaling in the regulation of breast cancer development and progression;(2) A genetic and molecular understanding of locally advanced breast cancer, a persistently under-studied form of breast cancer common among the medically underserved and a leading presentation of breast cancer worldwide;(3) Development of new approaches and uses for radiation treatment in breast cancer;biological understanding of radiation-induced fibrosis;and molecular understanding of differential radiation effects on normal and breast tumor tissues;and (4) Induction of antitumor immunity through targeted control of the immune response by local radiation. Total funding has increased from $4,045,436 to $11,928,611. Membership has incresed from 34 to 44. Total publications for the past five years include 300 of which 13% are intra-programmatic and 16% are interprogrammatic.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
New York University
New York
United States
Zip Code
Pelzek, Adam J; Shopsin, Bo; Radke, Emily E et al. (2018) Human Memory B Cells Targeting Staphylococcus aureus Exotoxins Are Prevalent with Skin and Soft Tissue Infection. MBio 9:
Chiou, Kenneth L; Bergey, Christina M (2018) Methylation-based enrichment facilitates low-cost, noninvasive genomic scale sequencing of populations from feces. Sci Rep 8:1975
Jose, Cynthia C; Jagannathan, Lakshmanan; Tanwar, Vinay S et al. (2018) Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1. Mol Carcinog 57:794-806
Kourtis, Nikos; Lazaris, Charalampos; Hockemeyer, Kathryn et al. (2018) Oncogenic hijacking of the stress response machinery in T cell acute lymphoblastic leukemia. Nat Med 24:1157-1166
Formenti, Silvia C; Lee, Percy; Adams, Sylvia et al. (2018) Focal Irradiation and Systemic TGF? Blockade in Metastatic Breast Cancer. Clin Cancer Res 24:2493-2504
Snuderl, Matija; Kannan, Kasthuri; Pfaff, Elke et al. (2018) Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastoma. Nat Commun 9:2868
Stafford, James M; Lee, Chul-Hwan; Voigt, Philipp et al. (2018) Multiple modes of PRC2 inhibition elicit global chromatin alterations in H3K27M pediatric glioma. Sci Adv 4:eaau5935
Lee, Chul-Hwan; Yu, Jia-Ray; Kumar, Sunil et al. (2018) Allosteric Activation Dictates PRC2 Activity Independent of Its Recruitment to Chromatin. Mol Cell 70:422-434.e6
Aiello, Nicole M; Maddipati, Ravikanth; Norgard, Robert J et al. (2018) EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration. Dev Cell 45:681-695.e4
Jung, Heekyung; Baek, Myungin; D'Elia, Kristen P et al. (2018) The Ancient Origins of Neural Substrates for Land Walking. Cell 172:667-682.e15

Showing the most recent 10 out of 1170 publications